×
0 0 0.0597302504816955 0.0597302504816955 0.107899807321773 0.106936416184971 0.083815028901734 -0.0991425818882466
Stockreport

Akebia Therapeutics and Keryx Biopharmaceuticals to merge in all-stock deal [MarketWatch]

AKEBIA THERAPEUTICS (AKBA)  More Company Research Source: MarketWatch
Last akebia therapeutics earnings: 5/9 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF Akebia Therapeutics and Keryx Biopharmaceuticals to merge in all-stock deal Akebia Therapeutics Inc. AKBA, -3.80% and Keryx Biopharmaceuticals Inc. KERX, -8.94% said Thursday they have agreed to merge in an all-stock deal that will create a company focused on chronic kidney disease. The companies said the new entity will have pro forma equity value of about $1.3 billion, assuming full conversion of outstanding Keryx convertible notes. The new company will be called Akebia Therapeutics Inc. Under the terms of the deal, Keryx shareholders will recieve 0.37433 common share of Akebia for each Keryx share owned. Akebia CEO John Butler will lead the combined company and Keryx will appoint the chairman of the board. The deal is expected to close by year-end. "Combining Akebia and Keryx is expected to create a sustainable, kidney disease-focused, therapeutic leader that is well positioned to be a partner of choice throughout the renal community and for companies with products for patien [Read more]

IMPACT SNAPSHOT EVENT TIME: AKBA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AKBA alerts
from News Quantified